A detailed history of Keybank National Association transactions in Abb Vie Inc. stock. As of the latest transaction made, Keybank National Association holds 840,453 shares of ABBV stock, worth $148 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
840,453
Previous 848,733 0.98%
Holding current value
$148 Million
Previous $146 Million 14.01%
% of portfolio
0.65%
Previous 0.6%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $1.36 Million - $1.65 Million
-8,280 Reduced 0.98%
840,453 $166 Million
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $78,788 - $92,006
-509 Reduced 0.06%
848,733 $146 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $1,438 - $1,638
-9 Reduced -0.0%
849,242 $155 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $686,486 - $773,145
-4,989 Reduced 0.58%
849,251 $132 Million
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $1.93 Million - $2.23 Million
-14,412 Reduced 1.66%
854,240 $127 Million
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $1.59 Million - $1.98 Million
-12,025 Reduced 1.37%
868,652 $117 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $4.47 Million - $5.14 Million
-30,890 Reduced 3.39%
880,677 $140 Million
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $1.09 Million - $1.31 Million
-7,897 Reduced 0.86%
911,567 $147 Million
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $124,681 - $143,000
-929 Reduced 0.1%
919,464 $123 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $2.1 Million - $2.66 Million
-15,226 Reduced 1.63%
920,393 $141 Million
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $3.25 Million - $4.04 Million
-24,643 Reduced 2.57%
935,619 $152 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $810,989 - $1.03 Million
-7,549 Reduced 0.78%
960,262 $130 Million
Q3 2021

Nov 08, 2021

SELL
$106.4 - $120.78 $508,698 - $577,449
-4,781 Reduced 0.49%
967,811 $104 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $1.92 Million - $2.14 Million
-18,284 Reduced 1.85%
972,592 $110 Million
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $1.41 Million - $1.56 Million
-13,829 Reduced 1.38%
990,876 $107 Million
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $1.6 Million - $2.16 Million
-19,843 Reduced 1.94%
1,004,705 $108 Million
Q3 2020

Oct 29, 2020

SELL
$85.91 - $100.83 $919,151 - $1.08 Million
-10,699 Reduced 1.03%
1,024,548 $89.7 Million
Q2 2020

Aug 10, 2020

SELL
$73.37 - $98.18 $737,515 - $986,905
-10,052 Reduced 0.96%
1,035,247 $102 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $1.58 Million - $2.39 Million
-24,437 Reduced 2.28%
1,045,299 $79.6 Million
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $899,316 - $1.13 Million
-12,468 Reduced 1.15%
1,069,736 $94.7 Million
Q3 2019

Nov 04, 2019

SELL
$62.98 - $75.72 $3.94 Million - $4.74 Million
-62,582 Reduced 5.47%
1,082,204 $81.9 Million
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $2.22 Million - $2.84 Million
-33,816 Reduced 2.87%
1,144,786 $83.2 Million
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $5.4 Million - $6.36 Million
-70,010 Reduced 5.61%
1,178,602 $95 Million
Q4 2018

Jan 30, 2019

SELL
$77.85 - $96.01 $2.45 Million - $3.02 Million
-31,468 Reduced 2.46%
1,248,612 $115 Million
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $976,765 - $1.09 Million
-10,986 Reduced 0.85%
1,280,080 $121 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $634,565 - $750,833
-7,068 Reduced 0.54%
1,291,066 $120 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $1.31 Million - $1.75 Million
-14,234 Reduced 1.08%
1,298,134 $123 Million
Q4 2017

Feb 08, 2018

SELL
$89.56 - $98.21 $2.98 Million - $3.26 Million
-33,232 Reduced 2.47%
1,312,368 $127 Million
Q3 2017

Nov 02, 2017

SELL
$69.85 - $89.22 $309,854 - $395,779
-4,436 Reduced 0.33%
1,345,600 $120 Million
Q2 2017

May 14, 2018

SELL
N/A
-2,560 Reduced 0.19%
1,350,036 $97.9 Million
Q1 2017

May 14, 2018

SELL
N/A
-10,388 Reduced 0.76%
1,352,596 $88.1 Million
Q4 2016

May 14, 2018

BUY
N/A
1,362,984
1,362,984 $85.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.